Vale SA
XBER:CVLC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vale SA
XBER:CVLC
|
BR |
|
A
|
Apogee Therapeutics Inc
NASDAQ:APGE
|
US |
|
Avery Dennison Corp
NYSE:AVY
|
US |
|
B
|
Barnes Group Inc
XBER:BG4
|
US |
|
I
|
ID Logistics SAS
F:1ID
|
FR |
Wall St Price Targets
CVLC Price Targets Summary
Vale SA
According to Wall Street analysts, the average 1-year price target for CVLC is 11.391 EUR with a low forecast of 9.809 EUR and a high forecast of 12.781 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CVLC's stock price target?
Price Target
11.391
EUR
According to Wall Street analysts, the average 1-year price target for CVLC is 11.391 EUR with a low forecast of 9.809 EUR and a high forecast of 12.781 EUR.
What is the Revenue forecast for Vale SA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for Vale SA?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 5 years is 5%.
What is the Operating Income forecast for Vale SA?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 6 years is 0%.
What is the Pre-Tax Income forecast for Vale SA?
Projected CAGR
29%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 3 years is 29%.
What is the Net Income forecast for Vale SA?
Projected CAGR
22%
Over the last 14 years, the compound annual growth rate for Net Income has been -7%. The projected CAGR for the next 5 years is 22%.
